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C ommon among many vascular pathologies is an altered endothelial cell (EC) phenotype (ie, endothelial dysfunction).
1,2 A crucial aspect of EC dysfunction is compromised nitric oxide (NO) bioavailability that results from decreased NO synthesis and/or increased NO degradation. Molecular mechanisms responsible for endothelial dysfunction are unclear, and new targets for therapeutic intervention are required.
Autophagy is a highly conserved trafficking process through which intracellular components, including soluble proteins and protein aggregates, carbohydrates, lipids, membranes, cytoskeletal components, and organelles, are delivered to lysosomes. Cargo delivered to lysosomes by autophagy is degraded by lysosomal acid hydrolases, producing metabolites that can be recycled for use in new biosynthetic reactions, or diverted to metabolic pathways that generate ATP. Autophagy, therefore, plays a critical role in maintaining cellular homeostasis. 3, 4 Intriguing but limited evidence from human subjects suggests that compromised EC autophagy is associated with NO-mediated arterial dysfunction in the context of aging 5 and type 2 diabetes mellitus. 6 However, concurrent risk factors associated with aging and type 2 diabetes mellitus have potential to impair eNOS (endothelial NO synthase) activity independent from suppressed EC autophagy and cannot be overlooked as contributing to the dysregulated EC phenotype.
Earlier, we determined whether autophagy suppression per se compromises shear stress-evoked activation of eNOS and subsequent NO generation. 7 Shear stress increased autophagosome formation and NO generation in ECs. Genetic inhibition of autophagy by small interfering RNA (siRNA)-mediated knockdown of Atg3 (autophagocytosis-associated protein 3) prevented shear-induced phosphorylation of eNOS at its positive regulatory site S1117 (p-eNOS S1177 ), negated NO generation, amplified reactive oxygen species (ROS) production, and unleashed proinflammatory and adhesive responses, indicating that autophagy is critical for normal EC function. Although recent studies have confirmed our first report that shear stress increases indices of autophagy in ECs 8, 9 and arteries, 8 none have concurrently measured NO generation in the absence and presence of autophagy inhibition, and the mechanism(s) by which compromised autophagy in ECs jeopardizes shear-induced NO generation is unknown. The purpose of the present study was to determine the mechanism by which suppressed EC autophagy compromises shear-induced EC NO production.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Shear Stress Increases Autophagy and Mitochondrial Turnover in ECs
Bovine aortic ECs were exposed to no shear (−shear) or ≈20 dyn/ cm 2 Autophagy is an important regulator of mitochondrial turnover (ie, mitophagy). 10 We observed shear-induced degradation of mitochondrial aconitase and translocase of outer membrane 20 ( Figure IC and ID in the online-only Data Supplement), together with colocalization of translocase of outer membrane 20 with lysosome-associated membrane protein 1 ( Figure 1D and 1F) and translocase of outer membrane 20 with LC3 ( Figure IE and IF in the online-only Data Supplement). These latter findings demonstrate that mitochondrial turnover is elevated in response to shear stress.
Shear-induced LC3-II accumulation was greater, whereas p62 degradation was prevented in the presence versus the absence of bafilomycin A-1 ( Figure IG and IH in the onlineonly Data Supplement), confirming that shear stress increases autophagosome formation rather than decreases autophagosomal degradation by the lysosome. 7 All indices of shearinduced EC autophagy and mitophagy we measured were prevented by repressing Atg3 ( Using an alternative approach, shear-induced LC3:GFP puncta formation was negated by pharmacological inhibition of autophagy using the class III PI3K (phosphatidylinositol 3-kinase) inhibitor 3-methyladenine ( Figure 1C and 1E ). These data indicate that shear stress increases EC autophagy and mitophagy and demonstrate that genetic and pharmacological approaches we used to limit autophagy do not alter cell viability ( Figure IIA -IIC in the online-only Data Supplement).
Autophagy Suppression Limits Shear Stress-Induced NO Generation in ECs
Shear stress increased p-eNOS S1177 and NO generation in ECs transfected with scrambled but not Atg3 ( Figure 1G-1J 
Shear-Induced Phosphatase, Kinase, and ROS Signaling After Autophagy Suppression
Protein phosphatases and kinases, respectively, remove and add phosphate groups from target proteins, 11, 12 including eNOS. [13] [14] [15] [16] [17] Vascular PP2A (protein phosphatase 2A) activity is increased in pathologies associated with suppressed p-eNOS S1177 and compromised endothelial function. 16, [18] [19] [20] We observed no evidence that shear stress altered PP2A activation in the absence or presence of Atg3 siRNA.
To determine whether disrupted kinase signaling to eNOS might compromise NO synthesis secondary to repressed autophagy, we assessed p-Akt ( Figure VE in the online-only Data Supplement) and downstream targets (not shown), and this was pursued (see below). Exaggerated ROS production after Atg3 siRNA ( Figure  IVA in the online-only Data Supplement) has potential to decrease the synthesis of NO or increase the destruction of NO, and this was examined. Regarding NO synthesis, MAP kinases, such as p38-MAPK and ERK (extracellular signal regulated kinase), are phosphorylated/stimulated by nicotinamide adenine dinucleotide phosphate-generated ROS in vessels from mice with type 2 diabetes mellitus, which concurrently exhibit reduced p-eNOS S1177 and impaired vasorelaxation. 21 However, shear-induced p-ERK 1/2 and p-p38MAPK
were not altered by autophagy compromise ( Figure VC and VD in the online-only Data Supplement). Furthermore, pharmacological inhibition of mitogen-activated protein kinase using PD98059 ( Figure VC and VF in the online-only Data Supplement) and ERK 1/2 using FR180204 (not shown) did not restore blunted shear-induced p-eNOS S1177 ( Figure VF in the online-only Data Supplement) after autophagy suppression.
Amplified shear-induced ROS production after Atg3 siRNA has potential to precipitate NO destruction, and this was investigated. After its formation, O 2
•− reacts rapidly with NO to form peroxynitrite (ONOO − ). 22 ONOO − causes tyrosine nitration. Nitrotyrosine (ie, 3-NT) is an established estimate for ONOO − formation. 22 3-NT formation assessed via immunoblot ( Figure  VIA and VIB in the online-only Data Supplement) or ELISA (not shown) was not greater in ECs exposed to shear stress after autophagy compromise. To strengthen these findings, specific sources of ROS were inhibited in an attempt to restore shearinduced p-eNOS S1177 and NO generation in ECs after autophagy •− scavenger tiron, the complex IV inhibitor potassium cyanide, and the nicotinamide adenine dinucleotide phosphate oxidase inhibitor N-vanillynonanamide 23, 24 (not shown). The ability of 2′,7′-dichlorofluorescin diacetate fluorescence to detect ROS and results concerning cell viability ± the various antioxidant treatments are shown in Figure VIIC and VIID in the onlineonly Data Supplement, respectively.
Autophagy Suppression Compromises Glycolysis in ECs
Elevated p-AMPK T172 in ECs after autophagy compromise (Figure VE in the online-only Data Supplement) suggests an energy stress. ECs derive ATP primarily from glycolysis. 25, 26 We examined whether autophagy suppression evokes an energetic deficit in ECs. When ECs transfected with scrambled siRNA were exposed to shear stress, they displayed the expected increase in GLUT1 (glucose transporter 1) expression-the main glucose transporter in ECs-3H -deoxyglucose uptake, and cellular ATP production. Relative to control ECs, each response was prevented in ECs transfected with Atg3 (Figure 2A-2C ) or Atg5 siRNA (not shown). Because these data suggested that autophagy compromise impairs EC glycolysis, we measured the extracellular acidification rate (ECAR; a surrogate measure of lactic acid production) using the XF24 Seahorse Bioanalyzer. 27 Compared with ECs exposed to no shear, shear stress increased ECAR in ECs transfected with scrambled but not Atg3 siRNA, and results were similar under basal and maximal (ie, +carbonyl cyanide-4-[trifluoromethoxy] phenylhydrazone) conditions (Figure VIII in the online-only Data Supplement). These findings motivated us to complete a glycolysis stress test, that is, ECAR was assessed in ECs challenged with shear stress ± autophagy suppression under the following conditions: 0 mmol/L glucose, 5 mmol/L glucose (to stimulate glycolysis, lactate production, and increase ECAR), 1 µmol/L oligomycin (to inhibit mitochondrial ATP production), and 50 mmol/L 2-deoxyglucose (to inhibit glycolysis; Figure 2D ). Basal, glucose-stimulated, and oligomycin-stimulated ECAR was suppressed after Atg3 siRNA. As expected, 2-deoxyglucose inhibited ECAR in ECs transfected with scrambled but not Atg3 siRNA. These findings collectively indicate that EC autophagy suppression impairs EC glycolysis.
To determine whether impaired EC glycolysis after autophagy compromise might negate shear-induced NO generation, we first used a loss-of-function approach. ECs with ≈65% knockdown of GLUT1 via siRNA ( Figure IXA in the online-only Data Supplement) exhibited depressed shear-induced ATP production ( Figure 2E ) and were refractory to shear-induced p-eNOS S1177 ( Figure 2F ). Second, we used a gain-of-function approach. When ECs with suppressed autophagy were transfected with a plasmid vector that increased GLUT1 expression by ≈50% ( Figure  IXB 
Autophagy Suppression Impairs PurinergicMediated Activation of eNOS
It is established that ECs produce ATP in response to shear stress and that extracellular ATP/ADP signals via purinergic receptors to activate p-eNOS S1177 and NO generation. 28, 29 As would be predicted from cellular ATP results shown in Figure 2C , 2E, and 2G, shear-induced extracellular ATP accumulation was robust in ECs transfected with scrambled but not Atg3 siRNA ( Figure 3A) , prevented in control ECs transfected with GLUT1 siRNA ( Figure 3B) , and restored by GLUT1 overexpression in ECs with compromised autophagy ( Figure 3C ).
If limited extracellular ATP is responsible for suppressed shear-induced NO generation in ECs with compromised autophagy, then promoting extracellular ATP breakdown in ECs with intact autophagy or blocking the dominant purinergic receptor in ECs with intact autophagy 30 should independently recapitulate the phenotype displayed by ECs with impaired autophagy. Supporting this notion, shear stress did not increase p-eNOS S1177 when ECs transfected with scrambled siRNA were treated concurrently with apyrase, an ectonucleotidase that hydrolyzes ATP to AMP and inorganic phosphate (Figure 3D ), or MRS2179 (2′-deoxy-N 6 -methyladenosine 3′,5′-bisphosphate tetrasodium salt), a P2Y1 (P2Y purinoceptor 1) receptor blocker ( Figure 3E) . 31 A genetic approach was used to strengthen these findings. When the P2Y1 receptor was silenced by ≈45% via siRNA in ECs with intact autophagy ( Figure To validate that limited extracellular ATP contributes importantly to preventing shear-induced NO generation in ECs with compromised autophagy, we provided exogenous ADP to the cellular milieu in an attempt to restore NO production. ADP rescued shear-induced p-eNOS S1177 ( Figure 3G ) and NO generation ( Figure 3H 
Autophagy Suppression Impairs PurinergicMediated Activation of eNOS via PKCδ
T505
To this point, our data indicate that when autophagy is suppressed in ECs, a glycolytic defect limits shear-induced ATP production to an extent that purinergic-mediated activation of eNOS is compromised. We sought to identify the link between P2Y1 activation and eNOS phosphorylation. An exploration of the literature revealed that extracellular nucleotide-mediated activation of p-eNOS S1177 in human umbilical vein ECs exposed to shear stress occurs via p-PKCδ T505 (phosphorylated protein kinase C delta T505). 30 Because we did not assess this kinase originally, historical cellular homogenates treated ± shear ± Atg3 siRNA were retrieved, re-examined, and results indicated that shear-induced p-PKCδ T505 was prevented in ECs with suppressed autophagy ( Figure 4A ). Confirming the importance of this kinase in the context of the current experimental conditions, eNOS activation was refractory to shear stress in ECs transfected with PKCδ versus scrambled siRNA ( Figure 4B ; producing ≈40% reduction in PKCδ gene expression, Figure XIA in the online-only Data Supplement) and in ECs with intact autophagy treated with the PKCδ inhibitor rottlerin (not shown).
Using a gain-of-function approach, when ECs with suppressed autophagy were transfected with constitutively active PKCδ and subsequently challenged with shear stress, p-eNOS S1177 ( Figure 4C ) and NO generation ( Figure XIB and XIC in the Next, we confirmed that p-PKCδ T505 is a downstream target of purinergic-mediated signaling in our system. Specifically, phosphorylation of this kinase was refractory to shear stress in ECs with intact autophagy after transfection with P2Y1-receptor versus scrambled siRNA ( Figure 4E ). Substantiating these findings, shear stress evoked robust p-PKCδ T505 (and p-eNOS S1177 and NO generation; Figure 3G and 3H) in ECs with repressed autophagy that were treated concurrently with exogenous ADP (Figure 4F ).
Bryostatin-1 is a small molecule that binds with and directly activates PKCδ. [32] [33] [34] To determine whether pharmacological activation might preserve NO production in the context of suppressed autophagy, ECs ± Atg3 siRNA were treated ± shear stress ± bryostatin-1. Defective shearinduced PKCδ T505 , p-eNOS S1177 , and NO generation after autophagy compromise were restored by concurrent treatment with bryostatin-1 (Figure 4G-4I ; Figure XIIIA and XIIIB in the online-only Data Supplement). Taken together, our findings indicate that impaired EC autophagy represses glycolysis to an extent that extracellular ATP accumulation is limited, and purinergic signaling via the P2Y1-R and PKCδ to eNOS is blunted.
Translation to Human ECs and Intact Mice
We determined whether major findings observed in bovine aortic endothelial cells (BAECs) might be observed in human cells. Human arterial ECs were treated ± 20 dyn/cm 2 for 3 hours ± 5 mmol/L 3-methyladenine. Shear stress increased Atg3:GAPDH, LC3-II:GAPDH, p62 degradation, GLUT1:GAPDH, p-PKCδ These data are congruent with results from BAECs and demonstrate strong proof of concept for translational relevance.
Next, we examined whether major findings from ECs studied in vitro could be recapitulated in mice with compromised EC autophagy ( Figure 6A-6D) . Arterial ECs obtained from mice with tamoxifen-inducible deletion of Atg3 specifically in ECs (iecAtg3KO mice) exhibit the anticipated reduction in Atg3 protein expression and LC3-II:GAPDH, concurrent with suppressed GLUT1:GAPDH and p-eNOS S1177 :eNOS, versus results obtained from wild-type controls ( Figure 6E-6H) . Thus, several key nodes of dysregulation observed in BAECs and human arterial ECs studied in vitro after genetic and pharmacological repression of autophagy are recapitulated in vivo in mice with inducible disruption of EC autophagy. Studies are ongoing to determine the physiological and pathophysiological relevances of these findings.
Discussion
An understanding of the role that autophagy plays in maintaining cytoplasmic homeostasis in the context of health and disease is evolving. Evidence exists that autophagy can exert protective or adverse effects, and the respective response seems to be dynamic, context specific, and cell autonomous. Compared with other tissues, relatively little is known on vascular autophagy in general, and EC autophagy in particular, [35] [36] [37] but insight on the clinical relevance of EC autophagy is emerging. For example, the absence of endothelial autophagy markedly increased vascular lipid accumulation to an extent that elevated atherosclerotic burden in apolipoprotein E-deficient mice. 38 Our goal was to elucidate the molecular mechanisms by which repressed EC autophagy compromises EC NO generation. Rationale for investigating this issue is strong. For example, primary arterial ECs from 61-to 71-yearold (ie, old) humans and aortae from 27-to 28-month-old mice display markers of impaired autophagy and indices of lower NO bioavailability versus the appropriate controls. 5 Likewise, peripheral venous ECs obtained from diabetic patients exhibit depressed autophagy and blunted insulinstimulated p-eNOS S1177 . 6 Although these interesting studies provide proof of concept that impaired EC autophagy might precipitate compromised EC NO generation, the contribution from concurrent risk factors associated with aging and type 2 diabetes mellitus, with potential to impair eNOS activity independent from suppressed EC autophagy in primary ECs, cannot be overlooked.
Earlier, we reported that after transfection with Atg3 siRNA, ECs were refractory to shear-induced p-eNOS S1177 and NO generation, ROS accumulation was amplified, and inflammatory cytokine production was unmasked. 7 These findings were substantiated in the present study, extended to include autophagy suppression via Atg5 siRNA and class III PI3K inhibition using 3-methyladenine (Figure 1 ; Figures I and III in the online-only Data Supplement), and solid evidence is provided that key findings can be translated to human arterial ECs ( Figure 5 ) and intact mice ( Figure 6 ). In this study, we provide evidence for a unique mechanism by which compromised autophagy impairs shear-induced NO generation. Our first novel finding is that autophagy suppression impairs EC glycolysis. An initial exploration of candidate pathways that might be responsible for impaired NO synthesis and augmented NO destruction in ECs exposed to shear stress after Atg3 siRNA revealed that neither altered kinase signaling to eNOS, ROS-mediated eNOS enzyme disruption, nor ROSmediated conversion of NO to peroxynitrite was accountable. ECs derive ATP primarily from glycolysis, and when the resulting metabolic end-product lactate is exported from the cell, the pH of the extracellular milieu is lowered. 25, 26 By quantifying the ECAR in ECs under basal conditions, and in response to glucose stimulation, ATP synthase inhibition, and glycolysis inhibition, our suspicion of impaired EC glycolysis after autophagy suppression was supported (Figure 2) . Consistent with this, shear-induced expression of GLUT1, together with increased glucose uptake, cellular ATP production, and extracellular ATP accumulation, was prevented in ECs after Atg3 siRNA. Importantly, shear-induced NO generation in ECs after autophagy suppression could be rescued by GLUT1 overexpression, and congruent with these observations, shear-induced NO production was prevented in control ECs after GLUT1 siRNA. Taken together, we think these data are the first to indicate that autophagy suppression impairs EC glycolysis.
Our second original finding is that autophagy repression in ECs precludes purinergic-mediated eNOS phosphorylation and NO generation. Extracellular nucleotides have important biological roles as signaling molecules that regulate cellular functions under physiological and pathophysiological conditions. 29 eNOS is regulated at multiple levels, [39] [40] [41] [42] including via nucleotide activation of purinergic receptors. 29, 30, 43, 44 Shear stress stimulates the release of ATP in ECs, 30, 43, 45, 46 and its hydrolysis product ADP is an important ligand of purinergic receptor-mediated eNOS phosphorylation and NO generation. 30 Of the P2Y (G-protein-coupled receptors) and P2X (calcium channels) receptors located on ECs, the importance of P2Y receptor subtype 1 (P2Y1-receptor)-mediated eNOS activation and NO generation has been demonstrated in human umbilical vein ECs, 30 bovine aortic ECs, 43, 44 and cerebromicrovascular ECs. 47 Because shear stress failed to elevate cellular and extracellular ATP levels in ECs with suppressed autophagy, we thought it reasonable to test whether purinergic signaling to eNOS was compromised under these conditions. Pharmacological and genetic interference of the P2Y1 receptor in ECs with intact autophagy phenocopied results from ECs with compromised autophagy concerning shear-induced eNOS activation and NO generation, demonstrating the importance of purinergic signaling in general and this receptor subtype in particular. Consistent with these results, exogenous ADP restored shear-induced p-eNOS S1177 and NO generation in ECs with suppressed autophagy (Figure 3 ). These findings are the first to demonstrate that shear-induced purinergic-mediated activation of eNOS and resultant NO generation are impaired in ECs with suppressed autophagy.
The third important finding presented here is that PKCδ links purinergic-mediated signaling via the P2Y1 receptor to eNOS activation and NO generation. The PKC family of serine-threonine kinases includes conventional, novel, and atypical isoforms. 48 As the obtained data directed our focus toward purinergic signaling, we became aware of evidence from human umbilical vein ECs that shear stress increases extracellular nucleotide-mediated activation of p-eNOS S1177 via phosphorylation of the novel PKC isoform δ at threonine 505 (ie, p-PKCδ T505 ). 30 We observed that shear stress increases p-PKCδ T505 in ECs transfected with scrambled but not Atg3 siRNA and confirmed that p-PKCδ T505 is a downstream target of P2Y1-R-mediated signaling. Using a loss-of-function approach, eNOS activation was refractory to shear stress in ECs transfected with PKCδ versus scrambled siRNA and in ECs with intact autophagy treated with the PKCδ inhibitor rottlerin. Gain-of-function procedures substantiated these findings. Specifically, when ECs with suppressed autophagy were transfected with CA PKCδ or treated with a small molecule activator of PKC (ie, bryostatin-1), p-eNOS S1177 and NO generation were restored in response to shear stress (Figure 4) . The bryostatins are a family of 20 macrolide natural products isolated from the marine bryozoan Bugula neritina. 34 The biologically active constituent bryostatin-1 binds to the regulatory C1 domain of the PKC isoforms, 49 and clinical trials have investigated the therapeutic use of bryostatin-1 in the context of neurodegenerative diseases. 33, 50 Here, we provide evidence that genetic and pharmacological approaches to activate PKC can restore shear stress-mediated eNOS phosphorylation and NO generation in the context of impaired EC autophagy.
EC metabolism is an emerging but understudied therapeutic target. Metabolic abnormalities in ECs have potential to dysregulate vascular function in the context of numerous vascular pathologies. Initiating events that disrupt EC metabolism to an extent that precipitates EC dysfunction in the context of aging 51 and diabetes mellitus 52 are unclear. Here, we present solid evidence that impaired autophagy suppresses EC glycolysis, resulting in deficient ATP synthesis and release and defective purinergic signaling to eNOS via PKCδ. Many nodes of dysregulation in this pathway were revealed in human arterial ECs exposed to shear stress after pharmacological impairment of autophagy ( Figure 5 ) and several are recapitulated in adult mice with inducible disruption of autophagy specifically in ECs ( Figure 6 ). Current studies are investigating the functional role of EC autophagy in pre-clinical models of aging and diabetes mellitus.
